Skip to content

Clinical trials

Phase 3 Endometriosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometriosis Phase: Phase 3 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20091
20174
20181
20192
20205
20211
20221
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated5
Recruiting3
Active, not recruiting2
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kissei Pharmaceutical Co., Ltd.4
AbbVie3
Myovant Sciences GmbH3
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Milton S. Hershey Medical Center2
Sumitomo Pharma Switzerland GmbH2
Yale University2
Main Line Health1
OMRIX Biopharmaceuticals1
University of Michigan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometriosis21
Dysmenorrhea11
Dyspareunia6
Pelvic Pain6
Constipation4
Pain3
Infertility2
Leiomyoma2
Myofibroma1
Ovarian Cysts1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.